Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating)’s share price was up 3.4% during mid-day trading on Wednesday after Citigroup raised their price target on the stock from $6.00 to $8.00. The stock traded as high as $3.05 and last traded at $3.00. Approximately 348,426 shares traded hands during mid-day trading, a decline of 56% from […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating)’s stock price gapped up prior to trading on Friday . The stock had previously closed at $2.90, but opened at $3.06. Lexicon Pharmaceuticals shares last traded at $3.09, with a volume of 693,252 shares changing hands. Wall Street Analyst Weigh In A number of research analysts have issued […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) shares saw unusually-strong trading volume on Monday . Approximately 550,751 shares were traded during trading, a decline of 5% from the previous session’s volume of 579,683 shares.The stock last traded at $3.24 and had previously closed at $3.01. Analyst Upgrades and Downgrades Several research firms have weighed in […]
StockNews.com started coverage on shares of Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Rating) in a research report report published on Thursday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Separately, Jefferies Financial Group initiated coverage on shares of Lexicon Pharmaceuticals in a research note on Tuesday, March 7th. They set a hold […]
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX – Get Rating) saw a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 4,930,000 shares, an increase of 17.4% from the April 15th total of 4,200,000 shares. Based on an average daily volume of 607,900 shares, the days-to-cover ratio is […]